<DOC>
	<DOCNO>NCT00348387</DOCNO>
	<brief_summary>This study intend support registration IMOVAX Polio China . The primary objective Pase III trial compare IMOVAX Polio current Chinese standard care ( OPV ) administer follow schedule 2-3-4 month . The objective demonstrate 3 dos primary series , term seroprotection rate , IMOVAX Polio inferior OPV . The safety IPV assess IPV dose .</brief_summary>
	<brief_title>Immunogenicity Safety Imovax Polio Chinese Infants Compared Local OPV</brief_title>
	<detailed_description />
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 2 month ( 6070 day ) day inclusion study Born full term pregnancy ( 36 week ) birth weight ≥ 2.5 kg 2Ibs ) Parent ( ) legal representative able understand give authorization sign inform consent participation Able attend plan clinic appointment obey follow study instruction Taking part another clinical trial 4 week first trial vaccination Have plan take part another clinical trial trial period Inborn acquire decrease body natural defense , undertake treatment reduce body 's natural defense cancer drug , radiation past six month long term corticosteroid treatment Systemic reaction vaccine component history lifethreatening reaction study vaccine vaccine ingredient ( ) Prolonged long time illness could interfere study full participation Received blood bloodderived product since birth Received vaccine 4 week first trial vaccination give ( except BCG hepatitis B ) Have plan receive vaccine 4 week ( ) study vaccination give ( except DTacP ) Previous vaccination poliomyelitis infection trial vaccine another vaccine History poliomyelitis infection ( confirm either symptom , blood laboratory test ) Clinical serological evidence systemic illness include hepatitis B , hepatitis C Human immunodeficiency virus ( HIV ) Bleeding disorder low platelet allow vaccination muscle Had seizure past Febrile illness ( axillary temperature ≥ 37.1°C ) acute illness day inclusion</criteria>
	<gender>All</gender>
	<minimum_age>60 Days</minimum_age>
	<maximum_age>70 Days</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Imovax polio</keyword>
	<keyword>poliomyelitis</keyword>
</DOC>